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Abstract
Background: The aim of the study was to investigate urine matrix metalloproteinase (MMP-2 and
-9) activity, alkaline phosphatase/creatinine (U-AP/Cr) and gamma-glutamyl-transpeptidase/
creatinine (U-GGT/Cr) ratios, glucose concentration, and urine protein/creatinine (U-Prot/Cr)
ratio and to compare data with plasma MMP-2 and -9 activity, cystatin-C and creatinine
concentrations in colic horses and healthy controls. Horses with surgical colic (n = 5) were
compared to healthy stallions (n = 7) that came for castration. Blood and urine samples were
collected. MMP gelatinolytic activity was measured by zymography.
Results: We found out that horses with colic had significantly higher urinary MMP-9 complex and
proMMP-9 activities than horses in the control group. Colic horses also had higher plasma MMP-2
activity than the control horses. Serum creatinine, although within reference range, was significantly
higher in the colic horses than in the control group. There was no significant increase in urinary
alkaline phosphatase, gamma-glutamyltranspeptidase or total proteins in the colic horses compared
to the control group. A human cystatin-C test (Dako Cytomation latex immunoassay® based on
turbidimetry) did not cross react with equine cystatin-C.
Conclusion: The results indicate that plasma MMP-2 may play a role in the pathogenesis of equine
colic and urinary MMP-9 in equine kidney damage.
Background
Usually the detection of kidney damage can be made at a
relatively late stage by measuring serum creatinine and
urea concentrations because at the time of abnormal val-
ues 75% of nephrons are already damaged [1]. However,
depending on the cause and extend of damage, kidney has
ability to recover [2-5]. There is a need for tests that can
measure the early stages of kidney damage when there is
still a chance to prevent further damage. In the studies
made with laboratory animals the release of endotoxins
can affect kidney function [6,7]. In severe equine colic the
release of endotoxins is presumed to happen, but to our
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knowledge there are no studies on effects of endotoxins
on equine kidneys. The routine use of nephrotoxic drugs
like gentamicin, and non-steroidal anti-inflammatory
drugs preoperatively can further increase risk of damage to
the kidneys. For instance, even though gentamicin neph-
rotoxicity appears to be related to high or low levels of the
drug, it can occur at recommended doses. Additionally,
dehydration, and other drugs can affect the toxicity of gen-
tamicin. Moreover, a deterioration in renal function may
become evident for the first time or may progress after the
drug has been discontinued [8]. Gunson et al. [9] reported
that horses with both water deprivation and concurrent
administration of the non-steroidal drug developed acute
necrosis of the renal papilla, whereas the groups of horses
that received either non-steroidal drug or water depriva-
tion alone did not develop kidney damage.
A recent extensive review of all studies examining the clin-
ical utility of cystatin-C in humans concluded that serum
cystatin-C seems to perform at least as well as s-creatinine
as an indicator of renal function, and is probably more
sensitive than s-creatinine to small changes in GFR
[10,11]. In dogs cystatin-C concentration seemed to corre-
late with s-creatinine concentrations in chronic renal fail-
ure, although that correlation was not as good with
volume-depleted dogs [12]. No data exist regarding its use
as a marker of GFR in horses.
Matrix metalloproteinases (MMPs) were characterized ini-
tially by their extensive ability to degrade extra-cellular
matrix proteins. Some of the MMPs are involved in nor-
mal cell apoptosis and some are triggered by pathological
processes like inflammation, ischemia, necrosis, tumor
invasiveness, etc. Tashiro et al. [13] showed that patients
with type-2 diabetic nephropathy and microalbuminuria
had increased activity of urinary MMP-9 when s-creatinine
and BUN concentrations were still normal. Basile et al.
[14] showed that in rats kidney tissue MMP-2 activity
increased two- to threefold in days 1 to 3 after ischemic
acute renal failure and MMP-9 activity increased two- to
threefold in days 2 to 3. To our knowledge, MMP activities
in urine have not been measured in equine patients.
In humans, urine protein content is determined by col-
lecting urine during a 24 hour period. With animals this is
very unpractical and, therefore, urine protein concentra-
tion can be related to urine creatinine (U-Prot/Cr). Pro-
teinuria may occur with glomerular disease, pyuria or,
transiently, follow exercise [15]. In rhabdomyolysis large
amounts of myoglobin can also be passed into urine. Cur-
rently, for adult horses there are no reported reference val-
ues for U-Prot/Cr ratio in the literature.
Two enzymes often examined in urine when kidney dam-
age is suspected are alkaline phosphatase (AP), with its
several isoenzymes, and gamma-glutamyltranspeptidase
(GGT). In several studies with various species, an early
increase in urine enzyme activity in AP and GGT has been
found in the assessment of sub-clinical nephrotoxicity in
tubular cells. They preceded the detection of azotemia and
isosthenuria by several days in acute renal failure and by
up to several years in slowly developing chronic renal dis-
eases. [16-21] In healthy horses, there is no significant
diurnal variation in the activity of U-GGT and -AP within
the individual. Neither sex nor age seems to influence U-
GGT activity. [22]
The aim of this study was to find methods which can be
used to measure early damage to kidney function and find
out how colic affect horses' kidneys by investigating the
release of MMP-9 complexes, proMMP-9, MMP-9,
proMMP-2 and MMP-2, proteins, AP and GGT into urine
with horses that underwent an acute colic operation and
by comparing the data with urine and serum creatinine
levels and plasma MMP activities. We also wanted to
investigate whether a commercially available human
cystatin-C test can be used with equine patients.
Materials and methods
Selection of cases
Five horses (2 mares, 3 geldings) that underwent a colic
operation between September 2002 and November 2003
were included. Ages ranged from 2 to 11 years (mean 7.8
y) and weights, from 450 kg to 540 kg. All the colic horses
had received flunixin 1.1 mg/kg before coming to the
clinic. Some of the horses had also received benzylpenicil-
lin 10000 – 15000 IU/kg, B-vitamin, detomidine, xylazine
or fluid therapy before admission to the clinic. Clinical
signs varied from mild discomfort to heavy sweating and
restlessness. Three of the horses had been painful for
about 12 hours before the operation started (small intes-
tine volvulus, right dorsal displacement and left dorsal
displacement), one horse for 24 hours (with small intes-
tine impaction) and one horse had been colicky for 72
hours before the operation (right dorsal displacement).
Neither of the mares was pregnant.
Before anesthesia all the horses with colic were given ben-
zylpenicillin 40000 IU/kg and gentamicin 6.6 mg/kg i.v.
For sedation, some of the horses received acepromazine
and then detomidine (5–20 µg/kg). The more painful
horses were also given butorphanol for analgesia. Right
before induction, guaifenesin (50 mg/kg) was given, and
induction was performed with thiopental bolus.
The control group consisted of seven healthy stallions that
came for elective surgery (castration). Ages ranged from 1
to 10 years (mean 5.3 y) and weights from 130 kg to 565
kg (mean 395 kg). The study's protocol was approved byActa Veterinaria Scandinavica 2007, 49:4 http://www.actavetscand.com/content/49/1/4
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the local ethical committee, and informed owner consent
was obtained.
Experimental design and conditions
Blood was collected before anesthesia in all horses, and
urine was collected by spontaneous voiding in six of the
horses in the castration group and via a urinary catheter
soon after induction of anesthesia in the rest of the horses.
The plain blood samples were kept at room temperature
until serum was separated by centrifugation. The blood
samples in lithium heparin and the urine samples were
kept in iced water until centrifuged (1300 g, 10 min) at
4°C. A part of these samples were kept at 4°C until ana-
lyzed in the same day or next morning and the rest was
frozen to -70°C. Serum alkaline phosphatase (AP), urea,
creatinine (Cr), aspartate-aminotransferase (AST), sorbi-
tol dehydrogenase (SDH), plasma glucose, and creatine
kinase (CK) were all measured using routine laboratory
methods. Plasma cystatin-C was measured with Dako
Cytomation latex immunoassay®  (Dako Cytomation,
Denmark) based on turbidimetry (particle-enhanced tur-
bidimetric immunoassay, PETIA) using human cystatin-
C-specific antibodies. Plasma MMPs were measured using
gelatin zymography as described by Sepper et al. [23].
Before zymography, plasma samples were diluted to aqua
in relation 1:5 to minimize the covering effect of plasma
proteins to white bands.
Urine protein, Cr, AP, and GGT were measured using rou-
tine laboratory methods. Urine enzyme activities are given
in relation to urinary creatinine concentrations, that is, U-
GGT/Cr and U-AP/Cr (IU/mmol). The U-Prot/Cr relation
was calculated by multiplying it by 8.84 to convert creati-
nine µmol/L to mg/L [1]. Urine samples were cultured for
bacterial growth, and pH levels were recorded. All urine
samples were also analyzed by dipstick (Bayer Multistix®)
for occult blood and glucose. Proteolytic activity against
extra cellular matrix was measured by using SPS-PAGE gel-
atin zymography. Zymograms were analyzed for total
gelatinolytic activity, complex-, proMMP-9, active MMP-
9, and MMP-2 forms. The assays were performed essen-
tially as described by Sepper et al. [23]. Urine samples
were first mixed in a 2:1 ratio with sample buffer contain-
ing Brom Phenol Blue and protein denaturing 6% SDS
(pH 6.8), and preincubated for 30 min. Samples were
then loaded (15 µl) into the wells of a 10% gelatin gel (G-
2625, Sigma Chemicals Co., St Louis, MO, USA) and elec-
trophoresed at 4°C to avoid spontaneous activation. At
the same time Bio-Rad prestained SDS-PAGE standards
for low range molecular controls were run. The gel was
removed and incubated for 60 min in 100 ml of renatur-
ing buffer (2.5% Triton X-100) that was changed every 10
minutes. The gels were then incubated in +37°C for 18
hours and then stained with Coomassie blue as clear
bands against blue background. Activity was determined
by placing the gels on a scanner (Scanjet 4C/T, Hewlett-
Pacard, Palo Alto, Ca, USA) connected to an image analy-
sis and processing system (Cream tm, Kem-En-Tek,
Copenhagen, Denmark). Densitometeric results were cal-
culated in area mode (square pixels) after subtraction of
background grey values.
Statistical methods
The results were calculated by SPSS for Windows. The data
were analyzed by the one-sample Kolmogorov-Smirnov
test for normal distribution. Normally distributed data
were analyzed by the Student's t-test to compare between
groups. Non parametric data, including urine and plasma
MMP activities, were analyzed using the Mann-Whitney
test to compare between groups. The minimum statistical
difference was taken as p < 0.05.
Results
Plasma MMP-2 activity was higher in colic horses (p =
0.009) compared to the control group. (Fig. 1)
Mean serum creatinine concentrations were significantly
higher in the colic group (p = 0.03), although within ref-
erence range in both groups. (Table 1)
Mean ± s.d. plasma gelatinolytic activity in control group   and in colic group ■ Figure 1
Mean ± s.d. plasma gelatinolytic activity in control group  
and in colic group ■ . MMP-9 complex, proMMP-9, MMP-9, 
proMMP-2 and MMP-2 activities are expressed as an area 
under the brightness-to-width curve of each gelatinolytic 
band in zymogram.
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Plasma cystatin-C concentrations were below the thresh-
old level (<0.39 mg/l) when using human immunoturbi-
dimetric assay.
The activity of urinary proMMP-9 was higher in the colic
group (p = 0.03) than in the control group. (Fig. 2) Three
out of five colic horses had MMP-9 complexes in urine
compared to none in the control group (p = 0.025). Active
MMP-9 concentration tended to be higher in the colic
horses, although the difference was not statistically signif-
icant.
The mean urine protein/creatinine (U-Prot/Cr) ratio was
less than 2.0 in control group samples but above it in colic
group samples. (Table 2) The difference was not statisti-
cally significant.
Mean U-GGT/Cr and U-AP/Cr ratios were above reference
ranges in the colic group. (Table 2)
U-gluc was negative in all control horses. In the colic
group, it was positive in 2 horses of 5. (Table 2)
All urine bacterial growth samples were negative.
Discussion
The horses with colic in this study had been administered
potentially nephrotoxic drugs such as NSAIDs, and gen-
tamicin and they were most probably also endotoxemic
before the operation. Matrix metallo proteinases may play
a role in the pathogenesis of endotoxemia. Raulo et al.
[24] inoculated cows with endotoxin and detected an
increase in MMP-2 activity in milk after two hours and an
increase in capillary permeability, evidenced first by the
penetration of small molecular weight proteins, and 6 to
12 hours post endotoxin inoculation, by neutrophilic leu-
cocytes. Albert et al. [25] showed that in humans plasma
activity of MMP-9 increased 30-fold in 2 hours after endo-
toxin stimulation and fell after 4 to 6 hours. In our study,
plasma MMP-2 activity increased in all colic horses. MMP-
2 is related to changes in cell permeability which is pre-
sumed to happen in colic. Molecules that are smaller than
68 kDa can pass through glomerular filtration. But in
most healthy animals the proteins are reabsorbed in the
proximal tubules and, thus, very little or no protein is
detected in urine samples [1]. ProMMP-2 has a weight of
72 kDa and MMP-2 a weight of 59–62 kDa. Inactive
proMMP-9 weighs 92 kDa, but after activation it weighs
between 68 and 82 kDa [26]. In our study, urine MMP-9
complexes and both proMMP-9 and MMP-9 activities
increased in colic horses which can be related to early
tubular damage because these molecules cannot pass
through glomerular basement membrane due to high
molecular weight. Further studies need to be done to
determine the time span over which gelatinolytic activity
increases in acute tubular damage.
Unfortunately, the human cystatin-C test did not seem to
work in equine patients, which indicates that there is no
Mean ± s.d. urine gelatinolytic activity in control group  and  in colic group ■ Figure 2
Mean ± s.d. urine gelatinolytic activity in control group  and 
in colic group ■ . MMP-9 complex, proMMP-9, MMP-9, 
proMMP-2 and MMP-2 activities are expressed as an area 
under the brightness-to-width curve of each gelatinolytic 
band in zymogram.
proMMP-9 proMMP-2 MMP-9 MMP-2 complex
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500
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0
Table 1: Mean concentrations of serum Cr and glucose in horses with surgical colic (n = 5) and in healthy controls (n = 7).
mean ± s.d. (range) Reference values
Control S-Cr (µmol/L) 113.7 ± 15.7 (90.0–135.0) <168 [34]
Colic 146.0 ± 15.9 (126.0–162.0)
Control S-Gluc (mmol/L) 5.7 ± 0.6 (5.0–6.8) < <8.3–9.7 [27]
Colic 11.0 ± 4.1 (6.5–16.6)
Colic with glucosuria 12.7 ± 4.3 (8.1–16.6)Acta Veterinaria Scandinavica 2007, 49:4 http://www.actavetscand.com/content/49/1/4
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or very little cross-reactivity between the human cystatin-
C specific antibody and equine cystatin-C.
Because no reference values for the U-Prot/Cr ratio for the
adult horse could be found in the literature, we followed
tentatively Shott's [27] suggestion that values above 2.0 be
considered abnormal for horses. In dogs this ratio is con-
sidered normal when the U-Prot/Cr is < 0.5 and, border-
line between values 0.5–1.0. In dogs with glomerular
proteinuria the ratio is >1.0 [27]. In normal 4–5 day old
foals Brewer et al. [28] reported a U-Prot/Cr ratio of 0.9 ±
0.5 (1 SD). The mean U-Prot/Cr ratios in the control
group were all below 2.0, whereas in the colic group they
were elevated when all the horses were included. How-
ever, there was one horse with rhabdomyolysis and when
that horse was excluded the mean U-Prot/Cr ratio was
1.22, suggesting that no proteinuria indicative to tubular
damage could be detected.
None of the control group horses had glucose in their
urine, but in the colic group three horses (all the horses
that did not eventually survive) had glucose in their urine.
Two of these horses had a plasma glucose concentration
above the proposed renal threshold of 9.7 mmol/l [27]
which can be due to an increase in cortisol or catecho-
lamines. Scheinin and McDonald [29] reported that α2-
agonists reduce insulin release from the pancreas and,
thus, cause transient hyperglycaemia. On the other hand
renal damage to the proximal tubulus cells and their
reduced ability to absorb glucose could cause leakage in to
urine. Brashier et al. [30] reported glucosuria in ponies
with gentamicin-induced nephrotoxicosis. In their study,
blood glucose concentrations were below the renal
threshold for glucose all the time and glucose appeared in
the urine 2–3 days before the S-Cr concentration became
abnormally high.
In the study of Adams et al. [31] U-GGT/Cr ratio was 1.13
± 0.54 IU/mmol Cr for healthy adult horses. Views on
what constitutes a clinically significant rise of U-GGT/Cr
vary: Kohn and Chew [32] suggested that values above
2.83 IU/mmol (> 25 IU/gCr) were significant, whilst
Schott [27] considered a U-GGT/Cr ratio more significant
when it is above 11.3 IU/mmol Cr (>100 IU/g Cr) for an
adult horse. In our study these enzyme values were clearly
below that.
All the mean U-AP/Cr ratios were abnormally high when
compared to the "normal" values in the study done by
Brobst et al. [22], namely 0.76 ± 0.40 IU/mmolCr, but
within normal limits when compared to the study by
Edwards et al. [33], namely 2.10 ± 1.45 IU/mmolCr.
Schott [25], however, has suggested that a clinically signif-
icant rise in U-ALP/Cr is above 3.17 IU/mmol Cr. For
dogs, values higher than 20 IU/mmolCr are considered
abnormal [20]. In our study the control group horses were
all stallions that might have a higher, but still, normal
enzyme activity in urine, due to glandular secretions, than
geldings or mares. In those samples that were collected in
spontaneous urination these secretions could be involved.
On the other hand, it may be questionable to compare
enzyme activities measured in different laboratories, as
there may be differences in the analytical methods.
S-Cr concentration was higher in the colic group,
although within reference range. This could be due to
reduced renal blood flow because of endotoxemia, or/and
NSAID administration and a failure to correct dehydra-
tion, because urine enzyme activity was only moderately
increased.
Because of the lack of studies it is difficult to determine
the threshold values for urine enzymes which in turn
makes it difficult to decide whether there is a thread of
renal insufficiency that needs to be addressed or transient
or reversible kidney damage that does not affect the prog-
nosis of the animal.
The problem with our preliminary study was the small
group sizes. However, even with these small group sizes
some statistically significant differences between groups
could be detected in MMP-activities, even though cell
death may have begun, changes in urine enzyme and pro-
tein content might occur later on. In many studies where
Table 2: Mean concentrations of urine GGT/Cr, AP/Cr (IU/mmol Cr) Prot/Cr (mg/mg) and glucose in horses with surgical colic (n = 5) 
and in healthy controls (n = 7).
mean ± s.d. (range) Reference values for adult horses
Control U-Prot/Cr (mg/µmol Cr × 8.84) 1.06 ± 1.40 (0.33–4.17) <2.0 [27]
Colic 2.17 ± 2.20 (0.67–5.94)
Control U-GGT/Cr (IU/mmol) 1.14 ± 0.53 (0.34–1.94) 1.13 ± 0.54 [31]
Colic 5.87 ± 10.61(0.90–24.87)
Control U-AP/Cr (IU/mmol) 1.93 ± 1.17 (0.56–3.6) 2.10 ± 1.45 [33]
Colic 3.13 ± 2.17 (1.12–6.45)
Control U-Glucose (+drystix) 0.00 <00 [27]
Colic 0.80Acta Veterinaria Scandinavica 2007, 49:4 http://www.actavetscand.com/content/49/1/4
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acute kidney damage has been induced by toxic agents,
elevated urine enzymes have often been recorded only
after several days [16,19,20]. In other studies it has been
recorded that urine GGT and AP activities often return to
baseline even though S-Cr is still rising, so single samples
in the middle of the disease process can give normal val-
ues even though kidney damage is progressing [16]. Urine
enzyme activities did not correlate in this early phase with
either S-Cr concentration or urine MMP activities, which
suggests that enzymes enter the urine in bursts rather than
in one continuous flow after tubular cell death has
occurred.
Conclusion
The results indicate that plasma MMP-2 may play a role in
the pathogenesis of equine colic and urinary MMP-9 in
equine kidney damage.
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